Network-based assessment of HDAC6 activity is highly predictive of pre-clinical and clinical responses to the HDAC6 inhibitor ricolinostat [high throughput sequencing]
Ontology highlight
ABSTRACT: Network-based assessment of HDAC6 activity is highly predictive of pre-clinical and clinical responses to the HDAC6 inhibitor ricolinostat [high throughput sequencing]
PROVIDER: PRJNA625217 | ENA |
REPOSITORIES: ENA
ACCESS DATA